Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03816358
Brief Title: Anetumab Ravtansine With Nivolumab, Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Mesothelin Positive Advanced Pancreatic Cancer

First Submitted : January 24, 2019
First Submitted that Met QC Criteria : January 24, 2019
First Posted : January 25, 2019

Last Update Submitted that Met QC Criteria : April 16, 2019
Last Update Posted : April 17, 2019